DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

Announcement on Conversion Result of Convertible Bonds and Share Changes

· Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

DaShenLin Pharmaceutical Group Co., Ltd. has announced the results of its convertible bonds conversion and the resulting changes in share capital. As of a specified date, a small portion of the convertible bonds has been converted into shares, with the majority remaining unconverted. The report details the issuance of the convertible bonds, their conversion dates, and the adjustments made to the conversion price due to various corporate actions. The total number of shares has increased slightly due to the conversion of bonds into shares during the reporting period.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Conversion Result of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

All DaShenLin Pharmaceutical news releases